Skip to content
2000
Volume 31, Issue 21
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Introduction

Most Breast Cancer (BC) patients undergoing Radiotherapy (RT) are potentially susceptible to skin toxicity and prone to clinical symptom complaints. This study aimed to investigate the effect of oral Atorvastatin (ATV) administration on skin toxicity in BC patients undergoing RT.

Methods

One hundred BC patients were randomly assigned to oral ATV (40 mg) or placebo tablets two days before beginning the RT until the eighth week of the RT regimen was completed. Radiation-induced dermatitis was classified according to the Radiation Therapy Oncology Group (RTOG) criteria for eight weeks of treatment. In addition, during the eight weeks of RT, the clinical symptoms, such as pain, itching, burning, and sensitivity, were scored by patients in both groups according to the Visual Analogue Scale (VAS).

Results

Ninety-four BC patients were analyzed in this study. At the end of the seventh week of RT, the between-group analysis showed a statistically significant reduction of 20.7% in the ATV group (1.693 ± 0.846) compared to the placebo group (1.900 ± 0.986, = 0.036). However, the comparison of the dermatitis grade in the ATV and placebo groups showed a reduction of 54.5% in the ATV group; this difference was not statistically significant ( 0.072). The results of VAS regarding the clinical symptoms of patients showed pain, itching, burning, and sensitivity to touch to be clinically decreased in the ATV group compared to the placebo group in the 8 weeks, but these differences were not statistically significant.

Conclusion

According to the results of this clinical study, the oral administration of ATV at a dose of 40 mg during RT regimens can effectively reduce skin RT-induced toxicity and improve the self-report clinical symptoms among BC patients.

Clinical Trial Registration Number

IRCT20181005041239N1.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128343188241225193315
2025-01-24
2025-11-05
Loading full text...

Full text loading...

References

  1. Méndez-ValdésG. Gómez-HeviaF. BragatoM.C. Lillo-MoyaJ. Rojas-SoléC. SasoL. RodrigoR. Antioxidant protection against trastuzumab cardiotoxicity in breast cancer therapy.Antioxidants202312245710.3390/antiox1202045736830015
    [Google Scholar]
  2. GonulDR. AysegulCR. Skin toxicities and practices of patients receiving radiotherapy.Int. J. Caring Sci.2019121454464
    [Google Scholar]
  3. HosseinimehrS.J. GhasemiF. FlahatgarF. RahmanianN. GhasemiA. Asgarian-OmranH. Atorvastatin sensitizes breast and lung cancer cells to ionizing radiation.Iran. J. Pharm. Res.2020192808833224213
    [Google Scholar]
  4. VieiraL.A.C. MenêsesA.G. BontempoP.S.M. SiminoG.P.R. FerreiraE.B. GuerraE.N.S. ReisP.E.D. Incidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapy.Rev. Esc. Enferm. USP202256e2022017310.1590/1980‑220x‑reeusp‑2022‑0173en36469486
    [Google Scholar]
  5. GhasemiA. GhashghaiZ. AkbariJ. Yazdani-CharatiJ. SalehifarE. HosseinimehrS.J. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: A randomized, double-blind, placebo-controlled trial.Eur. J. Clin. Pharmacol.201975217117810.1007/s00228‑018‑2570‑x30291370
    [Google Scholar]
  6. PrasannaP.G. StoneH.B. WongR.S. CapalaJ. BernhardE.J. VikramB. ColemanC.N. Normal tissue protection for improving radiotherapy: Where are the Gaps?Transl. Cancer Res.201211354822866245
    [Google Scholar]
  7. YangX. RenH. GuoX. HuC. FuJ. Radiation-induced skin injury: Pathogenesis, treatment, and management.Aging20201222233792339310.18632/aging.10393233202382
    [Google Scholar]
  8. PiresA.M.T. SegretoR.A. SegretoH.R.C. RTOG criteria to evaluate acute skin reaction and its risk factors in patients with breast cancer submitted to radiotherapy.Rev. Lat. Am. Enfermagem200816584484910.1590/S0104‑1169200800050000819061020
    [Google Scholar]
  9. IacovelliN.A. TorrenteY. CiuffredaA. GuardamagnaV.A. GentiliM. GiacomelliL. SacerdoteP. Topical treatment of radiation-induced dermatitis: Current issues and potential solutions.Drugs Context2020911310.7573/dic.2020‑4‑732587626
    [Google Scholar]
  10. AcharyaU. CoxJ. RinksM. GaurP. BackM. Ability of radiation therapists to assess radiation-induced skin toxicity.J. Med. Imaging Radiat. Oncol.201357337337710.1111/1754‑9485.1203423721149
    [Google Scholar]
  11. MartinM.T. VulinA. HendryJ.H. Human epidermal stem cells: Role in adverse skin reactions and carcinogenesis from radiation.Mutat. Res. Rev. Mutat. Res.2016770Pt B34936810.1016/j.mrrev.2016.08.00427919341
    [Google Scholar]
  12. BazireL. FromantinI. DialloA. LandeB. PerninV. DendaleR. FourquetA. SavignoniA. KirovaY.M. Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial.Radiother. Oncol.2015117222923310.1016/j.radonc.2015.08.02826328937
    [Google Scholar]
  13. OliveiraK.A. Dal-CimT. LopesF.G. LudkaF.K. NedelC.B. TascaC.I. Atorvastatin promotes cytotoxicity and reduces migration and proliferation of human A172 glioma cells.Mol. Neurobiol.20185521509152310.1007/s12035‑017‑0423‑828181188
    [Google Scholar]
  14. SimY. LimC. PhyuN. TanK.T.B. ChewL.S.T. WongC.Y. MadhukumarP. YongW.S. LimS.Z. HamzahJ.L.B. TanS.Y. ChayW.Y. WongF.Y. TanP.H. TanV.K.M. The impact of statin use and breast cancer recurrence - A retrospective study in Singapore.Front. Oncol.20221283532010.3389/fonc.2022.83532035433431
    [Google Scholar]
  15. AlvandiM. ShaghaghiZ. DehbanpourM.R. FarzipourS. TalebpourAF. A review of effects of atorvastatin in radiotherapy.J. Mazandaran Univ. Med. Sci.202332217148168
    [Google Scholar]
  16. KoleAJ KoleL MoranMS Acute radiation dermatitis in breast cancer patients: Challenges and solutions.Breast Cancer2017931332310.2147/BCTT.S109763
    [Google Scholar]
  17. YeeC. WangK. AsthanaR. DrostL. LamH. LeeJ. VespriniD. LeungE. DeAngelisC. ChowE. Radiation-induced skin toxicity in breast cancer patients: A systematic review of randomized trials.Clin. Breast Cancer2018185e825e84010.1016/j.clbc.2018.06.01530072193
    [Google Scholar]
  18. JowkarF. NamaziM.R. Statins in dermatology.Int. J. Dermatol.201049111235124310.1111/j.1365‑4632.2010.04579.x20964647
    [Google Scholar]
  19. FigueroaC.R. The effect of interventions on radiotherapy-induced skin toxicity: A systematic review.UCF Theses and Dissertations.2020
    [Google Scholar]
  20. CoxJ.D. StetzJ. PajakT.F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC).Int. J. Radiat. Oncol. Biol. Phys.19953151341134610.1016/0360‑3016(95)00060‑C7713792
    [Google Scholar]
  21. Abdel-MagiedN. ShedidS.M. Impact of zinc oxide nanoparticles on thioredoxin-interacting protein and asymmetric dimethylarginine as biochemical indicators of cardiovascular disorders in gamma-irradiated rats.Environ. Toxicol.202035443044210.1002/tox.2287931749214
    [Google Scholar]
  22. AsghariM. ShaghaghiZ. FarzipourS. GhasemiA. HosseinimehrS.J. Radioprotective effect of olanzapine as an anti-psychotic drug against genotoxicity and apoptosis induced by ionizing radiation on human lymphocytes.Mol. Biol. Rep.20194665909591710.1007/s11033‑019‑05024‑x31407246
    [Google Scholar]
  23. Crevar-SakačM VujićZ Kotur-StevuljevićJ IvaniševićJ Jelić-IvanovićZ MilenkovićM Effects of atorvastatin and artichoke leaf tincture on oxidative stress in hypercholesterolemic rats.Mil. Med. Exam.201673217818710.2298/VSP140917148C
    [Google Scholar]
  24. SobhanM. GholampoorG. FirozianF. MohammadiY. MehrpooyaM. Comparison of efficacy and safety of atorvastatin 5% lotion and betamethasone 0.1% lotion in the treatment of scalp seborrheic dermatitis.Clin. Cosmet. Investig. Dermatol.20191226727510.2147/CCID.S19641231118730
    [Google Scholar]
  25. CavalcanteL.G. DominguesR.A.R. de OliveiraB.Junior FernandesM.A.R. PessoaE.C. AbbadeL.P.F. Incidence of radiodermatitis and factors associated with its severity in women with breast cancer: A cohort study.An. Bras. Dermatol.2024991576537657957
    [Google Scholar]
  26. ÖkçesizA. BucurgatÜ.Ü. Evaluation of toxic effects of statins and their possible role in treatment of cancer. İstanbul J. Pharm.2021511154160
    [Google Scholar]
  27. Talebpour AmiriF. HamzehM. NaeimiR.A. GhasemiA. HosseinimehrS.J. Radioprotective effect of atorvastatin against ionizing radiation-induced nephrotoxicity in mice.Int. J. Radiat. Biol.201894210611310.1080/09553002.2018.142092629268056
    [Google Scholar]
  28. NaeimiR.A. Talebpour AmiriF. KhalatbaryA.R. GhasemiA. ZargariM. GhesemiM. HosseinimehrS.J. Atorvastatin mitigates testicular injuries induced by ionizing radiation in mice.Reprod. Toxicol.20177211512110.1016/j.reprotox.2017.06.05228668617
    [Google Scholar]
  29. BourguillonRO StokesWA DorthJ SchmittNC Repurposing statin drugs to decrease toxicity and improve survival outcomes in head and neck cancer.OTO Open2021542473974X21106571510.1177/2473974X211065715
    [Google Scholar]
/content/journals/cpd/10.2174/0113816128343188241225193315
Loading
/content/journals/cpd/10.2174/0113816128343188241225193315
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test